Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients

Author:

Anzinger Isabel1,Nagel Dorothea2,De Toni Enrico N.3,Ofner Andrea3,Philipp Alexander B.3,Holdt Lesca M.2,Teupser Daniel2,Kolligs Frank T.4,Herbst Andreas3

Affiliation:

1. Department of Urology, St. Elisabeth Hospital, Straubing, Germany

2. Institute of Laboratory Medicine, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany

3. Medical Department 2, Faculty of Medicine, Ludwig Maximilians University, Munich, Germany

4. Helios Klinikum Berlin-Buch, Berlin, Germany

Abstract

BACKGROUND: Carcinoembryonic antigen (CEA) is the only established serum biomarker for colorectal cancer (CRC). To facilitate therapy decisions and improve the overall survival of CRC patients, prognostic biomarkers are required. OBJECTIVE: We studied the prognostic value of five different cell free circulating DNA (fcDNA) fragments. The potential markers were ALU115, ALU247, LINE1-79, LINE1-300 and ND1-mt. METHODS: The copy numbers of the DNA fragments were measured in the peripheral blood serum of 268 CRC patients using qPCR, the results were compared to common and previously described markers. RESULTS: We found that ALU115 and ALU247 fcDNA levels correlate significantly with several clinicopathological parameters. An increased amount of ALU115 and ALU247 fcDNA fragments coincides with methylation of HPP1 (P< 0.001; P< 0.01), which proved to be a prognostic marker itself in former studies and also with increased CEA level (both P< 0.001). ALU115 and ALU247 can define patients with poor survival in UICC stage IV (ALU115: HR = 2.9; 95% Cl 1.8–4.8, P< 0.001; ALU247: HR = 2.2; 95% Cl 1.3–3.6; P= 0.001). Combining ALU115 and HPP1, the prognostic value in UICC stage IV is highly significant (P< 0.001). CONCLUSIONS: This study shows that an increased level of ALU fcDNA is an independent prognostic biomarker for advanced colorectal cancer disease.

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference58 articles.

1. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt;Abo-Salem;Med Chem,2021

2. Circulating tumor cells and circulating tumor DNA;Alix-Panabières;Annual Review of Medicine,2012

3. M. Arnold, H.E. Karim-Kos, J.W. Coebergh, G. Byrnes, A. Antilla, J. Ferlay, A.G. Renehan, D. Forman and I. Soerjomataram, Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Registry database, European Journal of Cancer (Oxford, England: 1990) (2013).

4. Prognostic value of colorectal cancer biomarkers;Bianchi;Cancers,2011

5. Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: the EUROCARE study;Brenner;International Journal of Cancer,2012

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3